Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes.
about
Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data.Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition poreSulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among women.Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?Comparison of the micro- and macro-vascular effects of glimepiride and gliclazide in metformin-treated patients with Type 2 diabetes: a double-blind, crossover study.Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy.Pioglitazone and sulfonylureas: effectively treating type 2 diabetesCardiovascular events associated with second-line anti-diabetes treatments: analysis of real-world Korean data.Diabetes and the heart: could the diabetic myocardium be protected by preconditioning?Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?Treating diabetes today with gliclazide MR: a matter of numbers.Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks?The path to approval of new drugs for diabetes.Cardiovascular effects of anti-diabetes drugs.Do sulfonylurea drugs increase the risk of cardiac events?Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials.
P2860
Q31143283-E4D73CC1-1EFD-42C2-9E9A-AC0F96E2DE14Q34327908-B0E93BD7-837E-496B-8040-016E9F41599EQ34392375-03CD029C-1B69-43CF-9975-DE7722819AEFQ35607945-55AF383C-307E-47D3-9097-EFB94A3C79B9Q35825313-AEEA8CD0-ACCA-4093-B8D5-061B78138D35Q35847886-39B5E6DA-D30C-476D-BCB5-80F67F0A5E8FQ35987456-D8E08334-1578-454B-9984-DB5DEF9F87D0Q36376273-CBDA8FDB-BDBA-4470-9552-C871FF24B4ABQ36981806-4DF74477-2EE4-4DF4-9F54-90DE1D93F723Q37107490-8CF3ED0F-0B70-41CB-A184-8C4F61240A85Q37961238-B3FA3FC0-A5F6-4948-8D82-FBE13C658E96Q37992956-228B424B-3051-447A-A9BF-BC583A547366Q38080152-13093B7D-6FF7-418D-A886-E0254FF9916DQ38857056-568C33EF-E243-4F48-8290-FF46ED2781C4Q41142080-0A66274C-8075-40CE-8B72-8C8AE2393095Q43409321-54AF087B-2D95-4524-9D24-52CAD27236B5
P2860
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effects of treatment with sulf ...... ysfunction in type 2 diabetes.
@en
Effects of treatment with sulf ...... ysfunction in type 2 diabetes.
@nl
type
label
Effects of treatment with sulf ...... ysfunction in type 2 diabetes.
@en
Effects of treatment with sulf ...... ysfunction in type 2 diabetes.
@nl
prefLabel
Effects of treatment with sulf ...... ysfunction in type 2 diabetes.
@en
Effects of treatment with sulf ...... ysfunction in type 2 diabetes.
@nl
P2093
P1433
P1476
Effects of treatment with sulf ...... ysfunction in type 2 diabetes.
@en
P2093
Angelo Avogaro
Antonio Tiengo
Christian Negut
Eros Bagolin
Monica Palisi
Roldano Scognamiglio
Saula Vigili de Kreutzenberg
P304
P356
10.2337/DIABETES.51.3.808
P407
P577
2002-03-01T00:00:00Z